PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Brazilian Clinical Research Institute, São Paulo, Brazil; Rede D\'Or São Luiz (RDSL), São Paulo, Brazil. Electronic address: renato.lopes@dm.duke.edu.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Rede D\'Or São Luiz (RDSL), São Paulo, Brazil; Santa Casa de São Paulo, São Paulo, Brazil.\', \'Brazilian Clinical Research Institute, São Paulo, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Rede D\'Or São Luiz (RDSL), São Paulo, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.\', \'D\'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.\', \'Harvard Medical School, Boston, MA, USA.\', \'Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0002-8703(20)30138-110.1016/j.ahj.2020.05.002
?:hasPublicationType
?:journal
  • American heart journal
is ?:pmid of
?:pmid
?:pmid
  • 32502882
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.267
?:rankingScore_hIndex
  • 169
is ?:relation_isRelatedTo_publication of
?:title
  • Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32502882>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32502882>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all